BioXcel Therapeutics has offered a fast-action mouth-dissolving sublingual film formulation of dexmedetomidine.
Imeglimin is a universal anti-diabetic drug that incorporates the power of all existing glucose-lowering drugs.
Finerenone for the treatment of diabetic nephropathy, a chronic kidney disease associated with type 2 diabetes mellitus.
Sutimlimab will reduce the need for red blood cell transfusion due to hemolysis.
Avacopan is better than prednisone in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis.
Tisotumab vedotin for therapy of previously treated recurrent or metastatic cervical cancer.
Faricimab by Roche is a strong competitor to Eylea.